Cytotoxicity Studies to Characterize Self-Assembling Amphiphiles for Targeted Cancer Drug Delivery by Kim, Anne E.
Conclusions Background Analysis of Drug Analysis of Drug 
Cytotoxicity Studies to Characterize Self-Assembling Amphiphiles for 
Targeted Cancer Drug Delivery 
 
Anne E. Kim, Se Hye Kim, Samantha King, Aileen Shieh, and Jon R. Parquette* 
OSU College of Arts and Sciences, Department of Chemistry 
Acknowledgments 
Future Steps 
•  Parquette group; Department of Chemistry and 
Biochemistry 
•  Croce group; Department of Molecular Virology, 
Immunology, and Medical Genetics 
•  Prof. Mark Grinstaff, Boston University 
Advantages of nanodrugs in anticancer research 
•  Improves water solubility and drug stability 
•  Prolongs circulation time 
•  Increased target specificity 
•  Facilitates passive accumulation in tumors via 
enhanced permeation and retention effect 
S.K, Sahoo, Drug Discovery Today, 2012 
Camptothecin (CPT) 
•  Possesses potent antitumor properties that derive 
from its inhibition of topoisomerase I 
•  Showed remarkable anticancer activity in 
preliminary clinical trials 
•  Drawbacks: poor solubility under physiological 
conditions and unstable E-lactone ring 
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Self-Assembly of CPT-peptide conjugates 
•  Peptide conjugation to CPT increases stability of 
drug 
•  Preliminary data testing stability shows hydrolysis 
occurs at ester bond, not at lactone 
•  Hydrophilic portion (peptide) and hydrophobic 
portion (CPT) spontaneously assemble into 
nanotubes 
•  Once inside tumor cells, esterases will cleave ester 
bond à CPT will open to toxic form 
•  We have developed mono-, di-, and tetra-peptide 
conjugates 
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Compound 
•  Compound of interest is NH2-K(CPT)-NH2 
•  Monopeptide derivative is appealing due to simplicity, 
as opposed to di- and tetra-peptide 
•  Amide derivative is most favorable due to increased 
solubility, as opposed to methyl ester and free acid 
derivatives 
Imaging 
Nanotube formation – 250 µM in 
Phosphate Buffered Saline 
(PBS), was diluted from 10 mM 
stock solution (5.75 µg of drug in 
1.0 mL of PBS)  that was stored 
at 4 °C for 1-month, aged for 3-
days 23 °C 
Nanotube formation – 1 mM in 
PBS, was diluted from 10 mM 
stock solution (5.75 µg of drug in 
1.0 mL of PBS)  that was stored 
at 4 °C for 1-month, aged for 3-
days 23 °C 
Cytotoxicity Tests 
•  Cytotoxicity tests were conducted to determine half 
maximal inhibitory concentration (IC50) levels to 
test efficacy of drug 
•  3 non-small cell lung cancer cell lines (A549, H460, 
H23) with varying BCRP expression were used 
•  Drug was administered at varying concentrations 
and incubated with cells for 96 h 
•  Concentrations were diluted with PBS from 10 mM 
stock solution (5.75 µg of drug in 1.0 mL of PBS) 
that was aged at 23 °C for 3 days, stored at 4 °C in 
between trials 
•  Preliminary data 
•  IC50 levels of NH2-K were compared with CPT, 
CPT-11 (clinically approved), NH2-KK, and Ac-KK 
•  NH2-K appeared to be comparable to Ac-KK and 
less effective than NH2-KK 
•  Run E-lactone stability tests at pH 7.4 using high 
performance liquid chromatography 
•  Run more cytotoxicity trials to confirm preliminary 
data 
•  Quantitate accumulation of drug in vitro via flow 
cytometry 
•  Examine drug flow in cells with confocal images 
•  Determine biodistribution in vivo 
•  NH2-K(CPT)-NH2 shows promise based on 
collected data (TEM and cytotoxicity) so far 
•  There is formation of nanotubes due to 
amphiphilicity of molecule 
•  Cytotoxicity studies 
•  Seemed to have similar effectiveness as Ac-KK, 
but is less effective than NH2-KK 
•  Still more effective than CPT-11 (clinically 
approved drug) 
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